Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Brune

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1995
In vivo effects of a novel thromboxane A2/prostaglandin H2 (TXA2/PGH2) partial agonist, (+)5(Z)-7-[3-endo-phenylsulfonylamino[2.2.1]- bicyclohept-2-exo-yl]-heptenoic acid [(+)-S-145], on vascular, platelet and cardiac functionG P Dubé, J A Jakubowski, K A Brune, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2007
PancPRO: risk assessment for individuals with a family history of pancreatic cancerWenyi Wang, Sining Chen, Kieran A Brune, et al.
Journal of the National Cancer Institute|January 14, 2010
Importance of age of onset in pancreatic cancer kindredsKieran A Brune, Bryan Lau, Emily Palmisano, et al.
Hereditary Cancer in Clinical Practice|March 13, 2010
Patient perspective on the value of genetic counselling for familial pancreas cancerJennifer E Axilbund, Kieran A Brune, Marcia I Canto, et al.
Genetic Epidemiology|September 6, 2002
Evidence for a major gene influencing risk of pancreatic cancerAlison P Klein, Terri H Beaty, Joan E Bailey-Wilson, et al.
Applied and Environmental Microbiology|March 10, 2009
Genomic analysis of "Elusimicrobium minutum," the first cultivated representative of the phylum "Elusimicrobia" (formerly termite group 1)D P R Herlemann, O Geissinger, W Ikeda-Ohtsubo, et al.
Journal of Molecular and Cellular Cardiology|July 1, 1994
Characterization of thromboxane A2/prostaglandin H2 binding sites in guinea pig cardiac membrane preparationsN Bowling, G P Dubé, W L Kurtz, et al.
Molecular Pharmacology|January 11, 1991
Characterization of a thromboxane A2/prostaglandin H2 receptor in guinea pig lung membranes using a radioiodinated thromboxane mimeticD L Saussy, D E Mais, G P Dubé, et al.
Cancer Research|July 5, 2002
Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%Kathleen M Murphy, Kieran A Brune, Constance Griffin, et al.
Cancer Biology & Therapy|November 26, 2008
Absence of germline BRCA1 mutations in familial pancreatic cancer patientsJennifer E Axilbund, Pedram Argani, Mihoko Kamiyama, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1995
In vivo effects of a novel thromboxane A2/prostaglandin H2 (TXA2/PGH2) partial agonist, (+)5(Z)-7-[3-endo-phenylsulfonylamino[2.2.1]- bicyclohept-2-exo-yl]-heptenoic acid [(+)-S-145], on vascular, platelet and cardiac functionG P Dubé, J A Jakubowski, K A Brune, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2007
PancPRO: risk assessment for individuals with a family history of pancreatic cancerWenyi Wang, Sining Chen, Kieran A Brune, et al.
Journal of the National Cancer Institute|January 14, 2010
Importance of age of onset in pancreatic cancer kindredsKieran A Brune, Bryan Lau, Emily Palmisano, et al.
Hereditary Cancer in Clinical Practice|March 13, 2010
Patient perspective on the value of genetic counselling for familial pancreas cancerJennifer E Axilbund, Kieran A Brune, Marcia I Canto, et al.
Genetic Epidemiology|September 6, 2002
Evidence for a major gene influencing risk of pancreatic cancerAlison P Klein, Terri H Beaty, Joan E Bailey-Wilson, et al.
Applied and Environmental Microbiology|March 10, 2009
Genomic analysis of "Elusimicrobium minutum," the first cultivated representative of the phylum "Elusimicrobia" (formerly termite group 1)D P R Herlemann, O Geissinger, W Ikeda-Ohtsubo, et al.
Journal of Molecular and Cellular Cardiology|July 1, 1994
Characterization of thromboxane A2/prostaglandin H2 binding sites in guinea pig cardiac membrane preparationsN Bowling, G P Dubé, W L Kurtz, et al.
Molecular Pharmacology|January 11, 1991
Characterization of a thromboxane A2/prostaglandin H2 receptor in guinea pig lung membranes using a radioiodinated thromboxane mimeticD L Saussy, D E Mais, G P Dubé, et al.
Cancer Research|July 5, 2002
Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%Kathleen M Murphy, Kieran A Brune, Constance Griffin, et al.
Cancer Biology & Therapy|November 26, 2008
Absence of germline BRCA1 mutations in familial pancreatic cancer patientsJennifer E Axilbund, Pedram Argani, Mihoko Kamiyama, et al.
Pageof 5